HOOKIPA Pharma Inc. develops immunotherapeutics targeting infectious diseases and cancers. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers.
Market Cap | 85.466 Million | Shares Outstanding | 50.873 Million | Avg 30-day Volume | 291.38 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.05 |
Price to Revenue | 8.5457 | Debt to Equity | 0.0348 | EBITDA | -70.884 Million |
Price to Book Value | 0.843 | Operating Margin | -566.3994 | Enterprise Value | -11.54 Million |
Current Ratio | 5.478 | EPS Growth | -0.212 | Quick Ratio | 4.532 |
1 Yr BETA | 1.4505 | 52-week High/Low | 7.3 / 1.25 | Profit Margin | -523.5403 |
Operating Cash Flow Growth | -7.0331 | Altman Z-Score | -0.4972 | Free Cash Flow to Firm | -52.648 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
20,000 | 2022-06-30 | 1 | |
ALDAG JORN CHIEF EXECUTIVE OFFICER |
|
275,250 | 2022-06-30 | 3 |
|
40,000 | 2022-06-30 | 1 | |
MATUSHANSKY IGOR CHIEF MEDICAL OFFICER |
|
92,950 | 2022-06-30 | 4 |
KANDERA REINHARD CHIEF FINANCIAL OFFICER |
|
92,950 | 2022-06-30 | 3 |
ORLINGER KLAUS CHIEF SCIENTIFIC OFFICER |
|
48,350 | 2022-06-30 | 3 |
|
20,000 | 2022-06-30 | 1 | |
|
20,000 | 2022-06-30 | 1 | |
NECINA ROMAN CHIEF TECHNOLOGY OFFICER |
|
48,350 | 2022-06-30 | 3 |
BAKER CHRISTINE D. CHIEF OPERATING OFFICER |
|
100,000 | 2022-06-30 | 3 |
|
40,000 | 2022-06-30 | 2 | |
|
3,759,465 | 2022-02-15 | 1 | |
|
No longer subject to file | 2021-06-01 | 0 | |
|
9,600 | 2021-06-01 | 0 | |
|
9,600 | 2021-06-01 | 0 | |
|
3,177,574 | 2021-04-21 | 0 | |
|
2,485 | 2020-10-21 | 0 | |
LILJA ANDERS SR. VP, TECHNICAL DEVELOPMENT |
|
0 | 2020-01-23 | 0 |
|
No longer subject to file | 2019-04-23 | 0 | |
|
2,494,173 | 2019-04-23 | 0 | |
MORELAND MARK D CHIEF FINANCIAL OFFICER |
|
16,400 | 2011-11-21 | 0 |
PASTORE V SEBASTIAN EVP, BREWING OPERATIONS & LOG |
|
43,600 | 2011-09-06 | 0 |
|
19,284 | 2011-08-26 | 0 | |
WALL MARTIN J IV VICE PRESIDENT, SALES |
|
1,597 | 2011-08-23 | 0 |
|
3,894 | 2011-08-18 | 0 | |
MICHAELSON TERRY E CHIEF EXECUTIVE OFFICER |
|
25,299 | 2010-12-02 | 0 |
|
23,100 | 2009-04-06 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-07-01 16:06:47 -0400 | 2022-06-30 | A | 100,000 | a | 100,000 | direct | ||||||||||
2022-07-01 16:09:41 -0400 | 2022-06-30 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-07-01 16:08:31 -0400 | 2022-06-30 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-07-01 16:12:29 -0400 | 2022-06-30 | A | 20,000 | a | 20,000 | direct | ||||||||||
2022-07-01 16:11:31 -0400 | 2022-06-30 | A | 48,350 | a | 48,350 | direct | ||||||||||
2022-07-01 16:11:01 -0400 | 2022-06-30 | A | 92,950 | a | 92,950 | direct | ||||||||||
KANDERA REINHARD - Director - Officer CHIEF FINANCIAL OFFICER |
2022-07-01 16:07:51 -0400 | 2022-06-30 | A | 92,950 | a | 92,950 | direct | |||||||||
2022-07-01 16:15:25 -0400 | 2022-06-30 | A | 40,000 | a | 40,000 | direct | ||||||||||
2022-07-01 16:14:40 -0400 | 2022-06-30 | A | 40,000 | a | 40,000 | direct | ||||||||||
2022-07-01 16:13:31 -0400 | 2022-06-30 | A | 48,350 | a | 48,350 | direct | ||||||||||
2022-07-01 16:05:57 -0400 | 2022-06-30 | A | 275,250 | a | 275,250 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
HOOKIPA PHARMA INC HOOK | 2022-08-12 22:15:03 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 21:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 21:15:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 20:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 20:15:05 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 19:45:03 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 19:15:05 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 18:45:03 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 18:15:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 17:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 17:15:05 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 16:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 16:15:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 15:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 15:15:05 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 14:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 14:15:05 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 13:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 13:15:04 UTC | -6.2828 | 8.6028 | 1200000 |
HOOKIPA PHARMA INC HOOK | 2022-08-12 12:45:04 UTC | -6.2828 | 8.6028 | 1200000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | HOOK | -9000.0 shares, $-20520.0 | 2022-03-31 | N-PORT |